Chapter 3: Data Interpretation Flashcards

1
Q

Causes of anaemia (categorised by MCV)

A

Red blood cells:

  • Microcytic (low MCV) = iron deficiency anaemia, thalassaemia, chronic disease. Rare: lead poisoning, sideroblastic anaemia.
  • Normocytic (normal MCV) = anaemia of chronic disease, acute blood loss, combined haematinic disease, haemolytic anaemia, renal failure (chronic).
  • Macrocytic (high MCV) = B12/folate deficiency (megaloblastic anaemia), excess alcohol, liver disease (including non-alcoholic causes), hypothyroidism, “M” haematological causes (myeloproliferative, myelodysplastic, multiple myeloma).
    • B12 deficiency includes pernicious anaemia.

Myelodysplastic - immature blood cells do not mature. Often symptomless but later stages, sx depend on which cells are affected eg. SOB, tiredness, infections, bleeding, bruising

Neutropenia, anemia, and thrombocytopenia

Splenomegaly or rarely hepatomegaly

Can transform into AML

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Causes of neutrophilia

A

Neutrophilia (high) :

  • bacterial infection
  • tissue damage (inflammation/infarct/malignancy)
  • *steroids*.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Causes of Neutropenia

A

Neutropenia (low neutrophils)

  • viral infection
  • chemotherapy/radiotherapy (may become neutropenic in response to infection, neutropenic sepsis)
    • If neutropenic sepsis, must give urgent IV broad-spectrum antibiotics (hospital-specific).
  • clozapine (antipsychotic)
  • carbimazole (antithyroid).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Causes of lymphocytosis

A

Lymphocytosis (high lymphocyts)

  • viral infection
  • lymphoma
  • CLL.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Causes of Thrombocytopenia

A

Thrombocytopenia (low platelets)

  • reduced production
    • viral infection
    • drugs especially penicillamine in RA
    • myelodysplasia, myelofibrosis, myeloma
  • increased destruction
    • heparin
    • hypersplenism
    • DIC
    • ITP
    • HUS/TTP

Thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS) are multisystemic disorders characterized by thrombocytopenia, microangiopathic hemolytic anemia, and organ ischemia due to platelet agglutination in the arterial microvasculature.

1

Until recently, the classification of these syndromes was based primarily on clinical findings, with neurologic dysfunction being more prominent in TTP and renal dysfunction predominating in HUS. However, overlap is substantial, and precise distinction of the 2 syndromes remains somewhat arbitrary and controversial.

2

3

Recent evidence suggests that deficiency of a specific plasma protease responsible for the physiologic degradation of von Willebrand factor (vWF) multimers has a causative role in a large proportion of familial and idiopathic cases of TTP.

Although most cases of TTP and HUS are idiopathic, several etiologies and associations are well recognized, including infection, drugs, malignancy, chemotherapy, bone marrow transplantation (BMT), and pregnancy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Causes of thombocytosis

A

Thrombocytosis (high platelets)

  • reactive
    • bleeding
    • tissue damage e.g. infection/inflammation/malignancy
    • post-splenectomy
  • primary
    • myeloproliferative disorders
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Causes of hyponatraemia

Na+ 135-145 mmol/L

A

Hyponatraemia: assess fluid status first.

  • Hypovolaemic
    • fluid loss (D&V)
    • Addison’s
    • any diuretic.
  • Euvolaemic
    • SIADH
      • small cell lung tumours, _i_nfection, abscess, drugs (carbamazepine + antipsychotics), head injury.
    • psychogenic polydipsia
    • hypothyroidism.
  • Hypervolaemic
    • heart failure
    • renal failure
    • liver failure (hypoalbuminaemia)
    • nutritional failure (hypoalbuminaemia)
    • thyroid failure (hypothyroidism – can be euvolaemic too).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Causes of SIADH

A

SIADH

  • small cell lung tumours
  • infection
  • abscess
  • drugs (carbamazepine + antipsychotics)
  • head injury.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Causes of Hypernatraemia

A

Hypernatraemia: Causes all begin with “D”…

  • Dehydration.
  • Drips i.e. too much IV saline.
  • Drugs e.g. effervescent tablet preparations or IV preparations with high Na+ content.
  • Diabetes insipidus – opposite of SIADH.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Causes of Hypokalaemia (3.5-5mmol/L)

A

Hypokalaemia: DIRE

  • drugs (loop + thiazide diuretics)
  • inadequate intake or intestinal loss (D&V)
  • renal tubular acidosis
  • endocrine (Cushing’s + Conn’s syndrome).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Causes of Hyperkalaemia (3.5-5mmol/L)

A

Hyperkalaemia: DREAD

  • drugs (K+-sparing diuretics + ACE-i)
  • renal failure
  • endocrine (Addison’s disease)
  • artefact (clotted sample)
  • DKA (when insulin given to treat DKA, K+ drops so needs monitoring + replacement).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Link between urea and Hb

A

Hb broken down by gastric acid into Ur, then absorbed into blood

Ur rise = AKI or upper GI haemorrhage

GIH- you may find a low Hb, Ur rise.

nb isolated urea rise (without Creatinine rise) may be seen in pre-renal causes of renal failure e.g. DEHYDRATION

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Causes of pre-renal AKI

A

Pre-renal = U rise > C rise (U x 10 > C).

  • Dehydration (or if severe, shock) e.g. sepsis, blood loss.
  • Renal artery stenosis (often triggered by drugs e.g. ACEi or NSAIDs; renal hypoperfusion)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Causes of renal AKI

A

Intrinsic = U rise < C rise, no bladder or hydronephrosis.

INTRINSIC

  • ischaemic (prerenal AKI → ATN)
  • nephrotoxic antibiotics
    • gentamicin, vancomycin + tetracyclines
  • tablets
    • ACE-i, NSAIDs
  • radiological contrast
  • injury; rhabdomyolsis
  • negatively birefringent crystals (gout)
  • syndromes; glomerulonephritis
  • inflammation; vasculitis
  • cholesterol emboli.

Acute tubular necrosis is characterised by renal tubular cell damage and death and is usually caused by ischaemic or nephrotoxic insults. Deposition of cellular debris within the tubules results in oliguria.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Causes of post renal AKI

A

Post-renal = U rise < C rise, bladder or hydronephrosis.

  • In lumen = stone or sloughed papilla.
  • In wall = tumour (renal cell, transitional cell), fibrosis.
  • External pressure = benign prostatic hyperplasia, prostate cancer, lymphadenopathy, aneurysm.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

LFT:

  1. Markers of hepatocellular injury or cholestasis
  2. Synthetic function
A
  1. bilirubin, ALT, AST, ALP.
  2. Albumin, vit K dependent clotting factors (2,7,9,10) measure PT/INR
17
Q

Causes of raised bilirubin (3 categories)

A
  • Bilirubin rise only = pre-hepatic e.g.
    • haemolysis
    • Gilbert’s syndrome
    • Crigler-Najjar syndrome
  • Bilirubin + AST/ALT rise = hepatic e.g.
    • fatty liver
    • hepatitis
    • cirrhosis
      • Hepatitis + cirrhosis = alcohol, viruses (hepatitis A-E, CMV + EBV), drugs (paracetamol overdose).
    • malignancy; 1⁰ or 2⁰
    • metabolic; Wilson’s, haemochromatosis
    • HF
  • Bilirubin + ALP rise = post-hepatic i.e. obstruction…
    • In lumen = gallstones, drugs (flucloxacillin, co-amoxiclav, nitrofurantoin, steroids + sulphonylureas).
    • In wall = cholangiocarcinoma, PBC, PSC.
    • External pressure = pancreatic or gastric cancer, lymph nodes.

Crigler-Najjar syndrome is a rare genetic disorder characterized by an inability to properly convert and clear bilirubin from the body. Bilirubin is an orange-yellow bile pigment that is mainly a byproduct of the natural breakdown (degeneration) of old or worn out red blood cells (hemolysis).

The disorder results in a form of nonhemolytic jaundice, which results in high levels of unconjugated bilirubin and often leads to brain damage in infants.

18
Q

Causes of raised ALP

A

ALKPHOS

  • any fracture
  • liver damage (post-hepatic)
  • k for kancer
  • Paget’s + pregnancy
  • hyperparathyroidism
  • osteomalacia
  • surgery.
19
Q

Thyroid Fynction tests: and Changing levothyroxine!

A

Check TSH (0.5-5mIU/L), and change by smallest increment offered (unless grossly hypo/hyperthyroid).

  • <0.5 = decrease dose
  • 0.5-5 = nil action
  • >5 = increase dose.
20
Q

Abnormal TFTs: Hypothyroidism

A

Primary hypothyroidism = ↓T4 from thyroid so ↑TSH from pituitary = Hashimoto’s, drug-induced.

Secondary hypothyroidism = ↓TSH, so ↓T4 = pituitary tumour or damage.

21
Q

Abnormal TFTs: Hyperthyroidism

A

Primary hyperthyroidism = ↑T4, so ↓TSH = Grave’s, toxic nodular goitre, drug-induced.

Secondary hyperthyroidism = ↑TSH, so ↑T4 = pituitary tumour.

22
Q

Quick review of CXR:

PIPRA + ABCDEFGH

PSA=?pneumonia/pulmonary oedema

A

PIPRA:

  • Projection: PA (N, PA if no markings) or AP (can’t comment on heart) – should see from above clavicles to below diaphragm.
  • Inspiration: 7th anterior (down-sloping) rib transects diaphragm.
  • Penetration: vertebral bodies behind heart.
  • Rotation: distance between spinous processes + clavicles equal.
  • Artefact: if present.

ABCDEFGH:

  • Airways: trachea central – if not, consider collapse (towards) or pneumothorax (away).
  • Bone: rib fractures or lytic lesions.
  • Cardiac: cardiothoracic ratio <50% on PA film.
  • Diaphragm: air under diaphragm – bowel perforation or recent surgery; under L side is gastric bubble (N).
  • Edges: costophrenic + cardiophrenic angles sharp or blunt (effusion).
  • Fields: white area = effusion (unilateral + solid), pneumonia (unilateral + fluffy), oedema (bilateral + fluffy), fibrosis (bilateral + honeycomb).
    • Oedema, ABCDE = alveolar oedema, kerley B lines, cardiomegaly, diversion of blood to upper lobes, effusions.
    • Sail sign (triangle shape) behind heart = L lower lobe collapse.
  • Gynaecomastia + other soft-tissues.
  • Hila.

The hilum is visible as a triangular section at the inner midpoint of each lung. It is the space where vessels and nerves pass from your bronchus to your lungs. The hilum keeps your lungs anchored in place.

23
Q

Quick review of ABG

A
  • Check inspired oxygen concentration (FiO2):
    • Calculate N PaO2 for patient on oxygen: subtract 10 from FiO2, and if PaO2 exceeds this number, then patient not hypoxic.
      • E.g. On 60% oxygen with FiO2 of 30kPa actually hypoxic. Accurately done via arterial-alevolar gradient.
  • Check for respiratory failure: if PaO2 low or inappropriately N.
    • Type 1 = low or N PaCO2 (fast breathing) → heart/lung damage causing SOB.
    • Type 2 = high PaCO2 (slow breathing) → ‘blue-bloaters’ of COPD, NM failure or restrictive chest wall abnormalities.
  • Check acid-base status:
    • Low pH = acidosis; high pH = alkalosis.
    • PaCO2 abnormal = respiratory. HCO3 abnormal = metabolic. Both = compensation (fully if pH normal, otherwise partial). Both abnormal in opposite directions = mixed.
24
Q

Causes of the 4 acid base abnormalities

A

Respiratory alkalosis = rapid breathing – disease or anxiety.

Respiratory acidosis = same causes as T2RF. (COPD, blue bloaters, + neuromuscular failure + restrictive chest wall abn)

Metabolic alkalosis = vomiting, diuretics + Conn’s syndrome.

Metabolic acidosis = multiple causes e.g. lactic acidosis, DKA, renal failure, ethanol/methanol/ethylene glycol intoxication → narrow cause by using anion gap.

Aldosterone helps control blood pressure by holding onto salt and losing potassium from the blood. The increased salt increases the blood pressure.

25
Q

Quick review of ECG interpretation

A

Rate: divide 300 by # of large squares between each QRS complex; N = 60-100bpm/ based on the entire ECG being 10 seconds, count the number of QRS complexes and multiply by six.

Rhythm: p-waves present before QRS = sinus; PR interval not constant or >1 square = heart block → 1st degree = constant but >1 square, 2nd degree type 1 = increasing PR then misses a QRS, 2nd type 2 = PR intervals consistent but some p waves do not conduct, 3rd/complete = no relationship; no p waves + irregular QRS complexes = AF.

Axis: look at direction of I and II. If I +ve and II +ve = N; If I +ve and II –ve = LAD; If I –ve and II +ve = RAD.

Left leaning, right reaching

QRS: width <3 small squares = N ie 70-100ms [0.04x3=0.12s/120ms- max normal]

Narrow complexes (QRS < 100 ms) are supraventricular in origin.

Broad complexes (QRS > 100 ms) may be either ventricular in origin, or due to aberrant conduction of supraventricular complexes (e.g. due to bundle branch block, hyperkalaemia or sodium-channel blockade).

Narrow-complex; >3 = BBB – WiLLiaM = LBBB, rSR (M shape) in V6, MarRRoW = RBBB, rSR in V1.

V-waves: Add largest deflection in V1 to V6; >3.5 large squares = LVH (Sokolov-Lyon); small complexes/low voltage throughout = pericardial effusion.

ST segment: elevated = infarction (flat + some leads) or pericarditis (convex + all leads); depressed = ischaemia (flat + some leads) or digoxin (down-sloping, all leads).

T-waves: height > 2/3rd QRS height throughout ECG = hyperkalaemia; inversion = N in aVR + I, other leads = old infarction/LVH

26
Q

What criteria would suggest the need for monitoring

name 6 common drugs that require monitoring

A

Drug with narrow therapeutic index; small difference in blood concentration for therapeutic + toxic effects require monitoring

  1. digoxin
  2. theophylline
  3. lithium
  4. phenytoin
  5. ABx: gentamicin
  6. ABx: vancomycin
27
Q

What does drug monitoring entale (2 part)

A

Monitoring

  1. assess clinical state
    • response to drug
    • evidence of toxicity
  2. measure serum drug levels

→ adjust dose/frequency accordingly

28
Q

For what reasons is the dose/freq of a drug altered (4)

A

Inadequate response + low serum drug level = increase dose – in general by smallest possible increment, especially if 0-order kinetics (e.g. phenytoin).

Adequate response + N/low serum drug level = no change – clinical response more important, as already therapeutic dose!

Adequate response + high serum drug level = decrease dose – if toxicity, then can omit for few days (except gentamicin).

  • gent: pre-emptive decrease in frequency by 12hrs (e.g. 36 rather than 24hrs)

Toxicity + any serum drug level = (1) stop dose (+ alternative); (2) supportive measures (usually IV fluids); (3) give antidote

29
Q

Common signs of drug toxicity

  • Digoxin
  • Lithium
  • Phenytoin
  • Gentamicin
  • Vancomycin
A
  • Digoxin
    • confusion
    • nausea
    • visual halos
    • arrythmia
  • Lithium
    • early: tremor
    • intermediate: tiredness
    • Later: arrhythmias
    • seizures
    • coma
    • renal failure
    • diabetes insipidus
  • Phenytoin
    • gum hypertrophy
    • ataxia
    • nystagmus
    • peripheral neuropathy
    • teratogenicity
  • Gentamicin
    • ototoxicity
    • nephrotoxicity
  • Vancomycin
    • ototoxicity
    • nephrotoxicity
30
Q

Gentamicin normal dosing (&2 exceptions)

A

Gentamicin monitoring: IV aminoglycoside antibiotic used in severe infections.

Doses calculated via weight + renal function.

  • Most treated with high-dose regimen of 5-7mg/kg once-daily;
  • Renal failure patient recieve divided daily dosing (1mg/kg) 12-hourly
  • Endocarditis patients recieve divided daily dosing (1mg/Kg) 8-hourly

Must monitor as high risk of nephrotoxicity + ototoxicity.

31
Q

Gentamicin: Normal once daily regime monitoring

A

Risk of ototoxicity and nephrotoxicity

  • Measure gentamicin levels at particular times e.g. 6-14h after last gentamicin infusion started.
  • Use nomogram (specific to dose). If point on graph falls within 24h area, continue at same dose. If above 24h area, then change dosing:
    • If in 36h area, change to 36-hourly dosing.
    • If in 48h area, change to 48-hourly dosing.
    • If above 48h area, repeat gentamicin level and only re-dose when concentration <1mg/L.
  • Change frequency over dose as need sufficient dose to hit peak to hit minimum inhibitory concentration of organism.
32
Q

Gentamicine: divided daily dosing regimes + monitoring

A

Divided daily dosing: Nomogram exists, but daily peak and trough levels usually used instead.

  • Peak (1hr post dose) if outside of normal range (3-5mg/L (endocarditis) 5-10mg/L (all else)) adjust the dose
  • Trough (just before next dose) if outside of normal range (<1mg/L (endocarditis) <2mg/L (all else)) adjust the interval
33
Q

Management of paracetamol overdose (2)

A
  • Specific = N-acetyl cysteine (NAC) if appropriate.
    • Paracetamol metabolised by liver; relies on glutathione which is quickly depleted so toxic NAPQI accumulates. NAC replenishes it.
  • Supportive = particularly IV fluids.
34
Q

Warfarin Mechanism of action

A

Inhibits synthesis of vitamin K-dependent clotting factors (2, 7, 9 + 10) – prolongs PT from which INR derived.

35
Q

What is INR?

A

INR = ratio of patient PT to N population.

Normal INR = 1. INR

Only used to monitor warfarin – use PT for liver disease/ DIC

36
Q

Target INRs

A

Target INR for most = 2.5

if recurrent thromboembolism while on warfarin or metal replacement heart valves INR = 3.5.

37
Q

If major bleed i.e. causing hypotension or bleeding in confined space (brain or eye):

A
  1. Stop warfarin
  2. give 5-10mg IV vitamin K
  3. give prothrombin complex (e.g. Beriplex).
38
Q

How to manage over coagulation

A

If not bleeding, then look at INR to judge next step:

  • INR <6 = reduce warfarin dose.
  • INR 6-8 = omit warfarin for 2 days then reduce dose.
  • INR >8 = omit warfarin + give 1-5mg oral vitamin K.
  • If minor bleeding, with INR >5, give IV instead of oral vitamin K.